XPH vs. SBIO ETF Comparison

Comparison of SPDR S&P Pharmaceuticals ETF (XPH) to ALPS Medical Breakthroughs ETF (SBIO)
XPH

SPDR S&P Pharmaceuticals ETF

XPH Description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Grade (RS Rating)

Last Trade

$46.16

Average Daily Volume

40,383

Number of Holdings *

44

* may have additional holdings in another (foreign) market
SBIO

ALPS Medical Breakthroughs ETF

SBIO Description The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$38.26

Average Daily Volume

6,572

Number of Holdings *

83

* may have additional holdings in another (foreign) market
Performance
Period XPH SBIO
30 Days 4.18% 1.91%
60 Days 3.86% 2.27%
90 Days 9.06% 7.65%
12 Months 28.77% 52.91%
8 Overlapping Holdings
Symbol Grade Weight in XPH Weight in SBIO Overlap
ARVN C 2.76% 1.22% 1.22%
CORT B 4.32% 3.2% 3.2%
EWTX B 3.64% 2.03% 2.03%
FULC F 0.83% 0.34% 0.34%
LBPH A 4.15% 1.34% 1.34%
LQDA C 0.99% 0.58% 0.58%
PLRX A 0.93% 0.56% 0.56%
TARS A 2.36% 0.97% 0.97%
XPH Overweight 36 Positions Relative to SBIO
Symbol Grade Weight
BMY A 3.75%
ITCI A 3.49%
CTLT D 3.47%
JAZZ D 3.46%
JNJ D 3.44%
RPRX D 3.43%
VTRS B 3.43%
PFE D 3.41%
LLY F 3.36%
ZTS D 3.31%
AXSM C 3.3%
MRK F 3.18%
PRGO D 3.15%
ELAN D 2.98%
OGN D 2.93%
SAVA D 2.7%
AMPH A 2.25%
PBH A 2.22%
SUPN B 2.03%
PCRX C 2.01%
LGND A 1.72%
COLL F 1.69%
OCUL B 1.59%
ANIP F 1.57%
HROW C 1.46%
HRMY D 1.27%
AMRX B 1.24%
WVE B 1.16%
INVA C 1.02%
MNMD C 0.9%
EYPT C 0.87%
PHAT B 0.87%
ELVN B 0.75%
EOLS A 0.7%
NUVB F 0.49%
XERS A 0.49%
XPH Underweight 75 Positions Relative to SBIO
Symbol Grade Weight
RNA C -3.38%
KRYS C -3.33%
CRNX B -3.04%
ACLX B -3.02%
IMVT F -2.93%
ALKS F -2.88%
DNLI C -2.39%
MRUS C -2.38%
FOLD B -2.27%
ZLAB B -2.11%
PTCT B -2.05%
XENE C -2.03%
VRNA A -1.83%
PTGX B -1.77%
CGON F -1.67%
AGIO B -1.65%
IDYA F -1.61%
ACAD F -1.57%
GERN C -1.55%
VERA A -1.5%
KROS A -1.41%
VCEL D -1.35%
AKRO A -1.3%
MIRM B -1.25%
GLPG F -1.25%
CLDX F -1.21%
MNKD A -1.14%
BCRX A -1.1%
SNDX F -1.07%
IMCR F -1.06%
RCUS F -1.04%
NTLA F -1.03%
VRDN B -0.93%
SPRY B -0.92%
IRON D -0.9%
KURA F -0.89%
COGT B -0.89%
XNCR A -0.87%
DAWN A -0.85%
PHVS A -0.77%
APLT A -0.71%
AUPH A -0.65%
ANAB F -0.59%
PRTA F -0.58%
ETNB D -0.54%
REPL B -0.53%
ERAS C -0.48%
ANNX B -0.47%
OLMA F -0.46%
MLYS B -0.44%
YMAB A -0.43%
IRWD F -0.4%
CELC D -0.4%
ALLO D -0.38%
SVRA D -0.37%
FLGT C -0.37%
URGN F -0.35%
ARCT F -0.35%
AURA B -0.34%
ALT D -0.32%
ALEC D -0.3%
CMPS F -0.29%
AVXL A -0.29%
TBPH C -0.28%
FDMT F -0.27%
GHRS D -0.25%
ALDX D -0.21%
ACIU F -0.2%
INZY F -0.19%
STRO D -0.19%
ITOS F -0.19%
ENTA D -0.17%
VNDA D -0.17%
ZNTL D -0.15%
HLVX C -0.06%
Compare ETFs